Self‐Sampling for CDO1 / CELF4 Methylation Accurately Identifies Endometrial Cancer in a Resource‐Limited Region: A Prospective Study From Gansu

Timely diagnosis and risk stratification of endometrial cancer (EC) remain difficult in resource-limited regions. This prospective diagnostic accuracy and feasibility study evaluated whether self-collected cervical specimens combined with CDO1/CELF4 methylation testing, defined as the CISENDO assay, could identify histologically confirmed EC in symptomatic women from Gansu, northwest China. Of 302 screened women, 154 participants with self-collected specimens and histopathological diagnoses formed the primary analytic cohort; 35 had EC and 119 had non-EC diagnoses. An exploratory paired subset included 35 participants with both self- and physician-collected specimens. Diagnostic performance was assessed using receiver operating characteristic analysis and logistic regression, while paired sampling was evaluated using correlation, Bland-Altman analysis, and classification concordance. In self-collected specimens, CISENDO showed strong discrimination for EC at manufacturer-defined cutoffs (AUC 0.834). Bland-Altman mean differences were -1.05 ΔCt for CDO1 and -1.73 ΔCt for CELF4. CISENDO classifications were concordant in 31/35 paired specimens (88.6%), with positive agreement of 84.6%, negative agreement of 90.9%, and Cohen's κ of 0.76. CISENDO positivity remained the strongest independent predictor of EC after adjustment (adjusted OR 85.08; 95% CI 12.21-592.71; p < 0.001). Endometrial thickness showed modest discrimination (AUC 0.646) and did not improve performance when combined with CISENDO. Self-collected CISENDO testing showed strong discrimination for histologically confirmed EC and may provide a feasible molecular triage and risk-stratification approach for symptomatic women in underserved settings. This approach could support decentralized sample collection and reduce dependence on immediate specialist-based evaluation, particularly in geographically dispersed, resource-constrained populations.

Authors

Institutions

Publication Details

Journal
International Journal of Cancer
Published
2026-10-30
DOI
https://doi.org/10.1002/ijc.70776
Primary Topic
Cervical Cancer and HPV Research
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Self‐Sampling for CDO1 / CELF4 Methylation Accurately Identifies Endometrial Cancer in a Resource‐Limited Region: A Prospective Study From Gansu

Feixue Xu, Jiao Yang, 杨爱宏, Min Wei et al.
International Journal of Cancer
Cervical Cancer and HPV Research
article

Self‐Sampling for CDO1 / CELF4 Methylation Accurately Identifies Endometrial Cancer in a Resource‐Limited Region: A Prospective Study From Gansu

Feixue Xu, Jiao Yang, 杨爱宏, Min Wei, Yuqi Xin, Suyue Yin, Kaiya Zhao, Yishan Wang, Jia Wu, Xingyu Liu, Yu‐ligh Liou, Pei Liu, Panpan Yang
article en

Abstract

Timely diagnosis and risk stratification of endometrial cancer (EC) remain difficult in resource-limited regions. This prospective diagnostic accuracy and feasibility study evaluated whether self-collected cervical specimens combined with CDO1/CELF4 methylation testing, defined as the CISENDO assay, could identify histologically confirmed EC in symptomatic women from Gansu, northwest China. Of 302 screened women, 154 participants with self-collected specimens and histopathological diagnoses formed the primary analytic cohort; 35 had EC and 119 had non-EC diagnoses. An exploratory paired subset included 35 participants with both self- and physician-collected specimens. Diagnostic performance was assessed using receiver operating characteristic analysis and logistic regression, while paired sampling was evaluated using correlation, Bland-Altman analysis, and classification concordance. In self-collected specimens, CISENDO showed strong discrimination for EC at manufacturer-defined cutoffs (AUC 0.834). Bland-Altman mean differences were -1.05 ΔCt for CDO1 and -1.73 ΔCt for CELF4. CISENDO classifications were concordant in 31/35 paired specimens (88.6%), with positive agreement of 84.6%, negative agreement of 90.9%, and Cohen's κ of 0.76. CISENDO positivity remained the strongest independent predictor of EC after adjustment (adjusted OR 85.08; 95% CI 12.21-592.71; p < 0.001). Endometrial thickness showed modest discrimination (AUC 0.646) and did not improve performance when combined with CISENDO. Self-collected CISENDO testing showed strong discrimination for histologically confirmed EC and may provide a feasible molecular triage and risk-stratification approach for symptomatic women in underserved settings. This approach could support decentralized sample collection and reduce dependence on immediate specialist-based evaluation, particularly in geographically dispersed, resource-constrained populations.

International Journal of Cancer
Beijing Tsinghua Chang Gung Hospital (CN), First Hospital of Lanzhou University (CN), Tsinghua University (CN)
Openalex Percentile: Top 12%
Cervical Cancer and HPV Research
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon